Skip to main content

Table 4 Differences in Zearalenone and Deoxynivalenol levels in all studied breast milk by some mother-infant parameters*

From: Longitudinal follow-up of zearalenone and deoxynivalenol mycotoxins in breast milk in the first five months of life

 

n

Zearalenone, ng/mL

 

Deoxynivalenol, ng/mL

 

Mean [95% Wald CI]

p

Mean [95% Wald CI]

p

Sampling time

  

0.001

 

0.021

 Visit 1

19

0.62 [0.52–0.72]a

 

16.4 [12.0-20.8]ab

 

 Visit 2

19

0.46 [0.36–0.56]b

 

20.8 [16.4–25.2]a

 

 Visit3

19

0.37 [0.27–0.47]b

 

12.0 [7.6–16.4]b

 

Maternal education

  

0.663

 

0.236

 < 8 years

30

0.47 [0.38–0.56]

 

14.9 [11.2–18.5]

 

 ≥ 8 years

27

0.50 [0.41–0.59]

 

18.1 [14.2–22.0]

 

Smoking status

  

0.435

 

0.539

 No smoke exposure or smoking

19

0.45 [0.34–0.55]

 

17.8 [13.2–22.4]

 

 Maternal smoking +/-environmental smoke

10

0.57 [0.42–0.72]

 

13.3 [6.9–19.7]

 

 Environmental smoke w/o maternal smoke

28

0.48 [0.39–0.57]

 

16.5 [12.7–20.4]

 

Birth order

  

0.819

 

0.170

 First child

24

0.48 [0.38–0.57]

 

14.2 [10.1–18.3]

 

 ≥ second child

33

0.49 [0.41–0.57]

 

18.0 [14.5–21.5]

 

Infant sex

  

0.008

 

0.593

 Male

42

0.44 [0.37–0.51]

 

16.8 [13.7–20.0]

 

 Female

15

0.62 [0.50–0.73]

 

15.2 [9.9–20.1]

 
  1. CI: Confidence Interval
  2. *Generalized Linear Models for each parameters; a,b Groups with different letters are statistically different from each other; p < 0.05